世界のタフェノキン市場予測（～2028年）：粉末、丸薬

• 英文タイトル：Global Tafenoquine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

• レポートコード：GIR-22E8972 • 出版社/出版日：GlobalInfoResearch / 2022年5月 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

タフェノキン市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界のタフェノキンの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 タフェノキン市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・粉末、丸薬 用途別セグメントは次のように区分されます。 ・三日熱マラリア原虫根治、熱帯熱マラリア原虫治療、マラリア再発予防 世界のタフェノキン市場の主要な市場プレーヤーは以下のとおりです。 ・GlaxoSmithKline Pharmaceuticals (GSK)、J & K Scientific LTD、BOC Sciences、WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd.、Pharmacodia (Beijing) Co.,Ltd、Amadis Chemical Company Limited、Merck 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、タフェノキン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要なタフェノキンメーカーの企業概要、2019年～2022年までのタフェノキンの価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要なタフェノキンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別タフェノキンの販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までのタフェノキンの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのタフェノキン市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、およびタフェノキンの産業チェーンを掲載しています。 ・第13、14、15章では、タフェノキンの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報（企業概要、製品概要、販売量、価格、売上）：GlaxoSmithKline Pharmaceuticals (GSK)、J & K Scientific LTD、BOC Sciences、WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd.、Pharmacodia (Beijing) Co.,Ltd、Amadis Chemical Company Limited、Merck ・メーカー別市場シェア ・地域別市場分析2017年-2028年 ・種類別分析2017年-2028年：粉末、丸薬 ・用途別分析2017年-2028年：三日熱マラリア原虫根治、熱帯熱マラリア原虫治療、マラリア再発予防 ・タフェノキンの北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ ・タフェノキンのヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア ・タフェノキンのアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア ・タフェノキンの南米市場規模2017年-2028年：ブラジル、アルゼンチン ・タフェノキンの中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Tafenoquine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Tafenoquine market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Radical Cure of P.vivax accounting for % of the Tafenoquine global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Powder segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Tafenoquine include GlaxoSmithKline Pharmaceuticals (GSK), J & K Scientific LTD, BOC Sciences, WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd., and Pharmacodia (Beijing) Co.,Ltd, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Tafenoquine market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Powder
Pills
Market segment by Application can be divided into
Radical Cure of P.vivax
P. falciparum Treatment
Prevention of Malaria Relapse
The key market players for global Tafenoquine market are listed below:
GlaxoSmithKline Pharmaceuticals (GSK)
J & K Scientific LTD
BOC Sciences
WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd.
Pharmacodia (Beijing) Co.,Ltd
Amadis Chemical Company Limited
Merck
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Tafenoquine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Tafenoquine, with price, sales, revenue and global market share of Tafenoquine from 2019 to 2022.
Chapter 3, the Tafenoquine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Tafenoquine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Tafenoquine market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Tafenoquine.
Chapter 13, 14, and 15, to describe Tafenoquine sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Tafenoquine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Tafenoquine Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Powder
1.2.3 Pills
1.3 Market Analysis by Application
1.3.1 Overview: Global Tafenoquine Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Radical Cure of P.vivax
1.3.3 P. falciparum Treatment
1.3.4 Prevention of Malaria Relapse
1.4 Global Tafenoquine Market Size & Forecast
1.4.1 Global Tafenoquine Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Tafenoquine Sales in Volume (2017-2028)
1.4.3 Global Tafenoquine Price (2017-2028)
1.5 Global Tafenoquine Production Capacity Analysis
1.5.1 Global Tafenoquine Total Production Capacity (2017-2028)
1.5.2 Global Tafenoquine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Tafenoquine Market Drivers
1.6.2 Tafenoquine Market Restraints
1.6.3 Tafenoquine Trends Analysis
2 Manufacturers Profiles
2.1 GlaxoSmithKline Pharmaceuticals (GSK)
2.1.1 GlaxoSmithKline Pharmaceuticals (GSK) Details
2.1.2 GlaxoSmithKline Pharmaceuticals (GSK) Major Business
2.1.3 GlaxoSmithKline Pharmaceuticals (GSK) Tafenoquine Product and Services
2.1.4 GlaxoSmithKline Pharmaceuticals (GSK) Tafenoquine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 J & K Scientific LTD
2.2.1 J & K Scientific LTD Details
2.2.2 J & K Scientific LTD Major Business
2.2.3 J & K Scientific LTD Tafenoquine Product and Services
2.2.4 J & K Scientific LTD Tafenoquine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 BOC Sciences
2.3.1 BOC Sciences Details
2.3.2 BOC Sciences Major Business
2.3.3 BOC Sciences Tafenoquine Product and Services
2.3.4 BOC Sciences Tafenoquine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd.
2.4.1 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Details
2.4.2 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Major Business
2.4.3 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Tafenoquine Product and Services
2.4.4 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Tafenoquine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Pharmacodia (Beijing) Co.,Ltd
2.5.1 Pharmacodia (Beijing) Co.,Ltd Details
2.5.2 Pharmacodia (Beijing) Co.,Ltd Major Business
2.5.3 Pharmacodia (Beijing) Co.,Ltd Tafenoquine Product and Services
2.5.4 Pharmacodia (Beijing) Co.,Ltd Tafenoquine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Amadis Chemical Company Limited
2.6.1 Amadis Chemical Company Limited Details
2.6.2 Amadis Chemical Company Limited Major Business
2.6.3 Amadis Chemical Company Limited Tafenoquine Product and Services
2.6.4 Amadis Chemical Company Limited Tafenoquine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Merck
2.7.1 Merck Details
2.7.2 Merck Major Business
2.7.3 Merck Tafenoquine Product and Services
2.7.4 Merck Tafenoquine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Tafenoquine Breakdown Data by Manufacturer
3.1 Global Tafenoquine Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Tafenoquine Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Tafenoquine
3.4 Market Concentration Rate
3.4.1 Top 3 Tafenoquine Manufacturer Market Share in 2021
3.4.2 Top 6 Tafenoquine Manufacturer Market Share in 2021
3.5 Global Tafenoquine Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Tafenoquine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Tafenoquine Market Size by Region
4.1.1 Global Tafenoquine Sales in Volume by Region (2017-2028)
4.1.2 Global Tafenoquine Revenue by Region (2017-2028)
4.2 North America Tafenoquine Revenue (2017-2028)
4.3 Europe Tafenoquine Revenue (2017-2028)
4.4 Asia-Pacific Tafenoquine Revenue (2017-2028)
4.5 South America Tafenoquine Revenue (2017-2028)
4.6 Middle East and Africa Tafenoquine Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Tafenoquine Sales in Volume by Type (2017-2028)
5.2 Global Tafenoquine Revenue by Type (2017-2028)
5.3 Global Tafenoquine Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Tafenoquine Sales in Volume by Application (2017-2028)
6.2 Global Tafenoquine Revenue by Application (2017-2028)
6.3 Global Tafenoquine Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Tafenoquine Sales by Type (2017-2028)
7.2 North America Tafenoquine Sales by Application (2017-2028)
7.3 North America Tafenoquine Market Size by Country
7.3.1 North America Tafenoquine Sales in Volume by Country (2017-2028)
7.3.2 North America Tafenoquine Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Tafenoquine Sales by Type (2017-2028)
8.2 Europe Tafenoquine Sales by Application (2017-2028)
8.3 Europe Tafenoquine Market Size by Country
8.3.1 Europe Tafenoquine Sales in Volume by Country (2017-2028)
8.3.2 Europe Tafenoquine Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Tafenoquine Sales by Type (2017-2028)
9.2 Asia-Pacific Tafenoquine Sales by Application (2017-2028)
9.3 Asia-Pacific Tafenoquine Market Size by Region
9.3.1 Asia-Pacific Tafenoquine Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Tafenoquine Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Tafenoquine Sales by Type (2017-2028)
10.2 South America Tafenoquine Sales by Application (2017-2028)
10.3 South America Tafenoquine Market Size by Country
10.3.1 South America Tafenoquine Sales in Volume by Country (2017-2028)
10.3.2 South America Tafenoquine Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Tafenoquine Sales by Type (2017-2028)
11.2 Middle East & Africa Tafenoquine Sales by Application (2017-2028)
11.3 Middle East & Africa Tafenoquine Market Size by Country
11.3.1 Middle East & Africa Tafenoquine Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Tafenoquine Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Tafenoquine and Key Manufacturers
12.2 Manufacturing Costs Percentage of Tafenoquine
12.3 Tafenoquine Production Process
12.4 Tafenoquine Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Tafenoquine Typical Distributors
13.3 Tafenoquine Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

---